Gliclazide: a classic sulfonylurea drug for diabetes treatment

Gliclazide is a sulfonylurea oral hypoglycemic drug, mainly used to treat type 2 diabetes. It regulates blood sugar by stimulating pancreatic beta cells to secrete insulin and improving the sensitivity of peripheral tissues to insulin. This article will cover drug mechanisms, indications, medication precautions and common products on the market to help readers fully understand its clinical application. The content is divided into five parts: an overview of the core functions and structure (with clear priorities), a detailed analysis of the pharmacological mechanism, indications and contraindications, medication safety tips, and finally a summary of its clinical value and market status.

Pharmacological mechanism and core functions

Gliclazide selectively acts on the sulfonylurea receptors on the pancreatic β-cell membrane to promote insulin release and enhance glucose uptake by muscles and adipose tissue, thereby reducing fasting and postprandial blood sugar. Compared with other sulfonylureas, it has a longer duration of action (about 10-12 hours) and may have slight antioxidant and microcirculation-improving effects. It should be noted that this drug is only suitable for patients who retain some pancreatic islet function and is not effective for type 1 diabetes.

Indications and Contraindications

Gliclazide is suitable for patients with type 2 diabetes who have poor diet and exercise control, especially for people with mild to moderate hyperglycemia. Contraindications include severe hepatic and renal insufficiency, gestational diabetes, ketoacidosis, and allergies to sulfonylureas. Elderly patients need to adjust the dose to avoid the risk of hypoglycemia. In clinical use, it is often used in combination with metformin, but you need to be alert to the synergistic hypoglycemic effect that may occur when combined with other antidiabetic drugs or alcohol.

Medication safety and adverse reactions

Common adverse reactions include gastrointestinal discomfort (such as nausea, bloating) and mild hypoglycemia, and rare skin allergies or blood system abnormalities. During the medication period, blood sugar and liver and kidney functions need to be monitored regularly to avoid hypoglycemia induced by missed meals or strenuous exercise. Patients should adjust the dosage according to the doctor's advice and should not increase or decrease it on their own. It is worth noting that gliclazide may enhance the efficacy of drugs such as warfarin, and coagulation function needs to be closely monitored.

Summary and Market Overview

As a classic antidiabetic drug, gliclazide is still widely used in clinical practice because of its accurate efficacy and low cost. Common domestic products include Dameikang (Servier Pharmaceuticals), Gliclazide Tablets (Yangzijiang Pharmaceuticals), etc. With the emergence of new antidiabetic drugs, their use needs to be more individualized, but they are still an important choice for primary care. Rational drug use requires weighing efficacy and safety, and formulating a plan based on the patient's specific situation.

Quote sources:
1. "China Type 2 Diabetes Prevention and Treatment Guidelines (2023 Edition)"
2. Servier Pharmaceuticals Damikang drug instructions
3. Yangzijiang Pharmaceutical Gliclazide Tablets Instructions